Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000685403 | SCV000812881 | likely benign | Duchenne muscular dystrophy | 2024-06-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440419 | SCV002746826 | uncertain significance | Cardiovascular phenotype | 2018-04-19 | criteria provided, single submitter | clinical testing | The p.L967R variant (also known as c.2900T>G), located in coding exon 22 of the DMD gene, results from a T to G substitution at nucleotide position 2900. The leucine at codon 967 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001829891 | SCV002089659 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2019-07-25 | no assertion criteria provided | clinical testing |